Pharma Journalist -

Horses with severe equine asthma struggle to breath, even at rest. This week, the European Commission granted marketing authorization1 to Boehringer Ingelheim for the new Aservo…
Read More...

SMi Group Will Merge with Tech Briefs Media Group to Form SAE Media Group WARRENDALE, Pa. (February 3, 2020) – SAE International announced today the acquisition of SMi Group Ltd, a…
Read More...

Navrogen, Inc., a biopharmaceutical company specialized in developing therapies for cancer and immune-related disorders, and Levena Biopharma, a company specialized in developing…
Read More...

Teva Pharmaceutical Industries Ltd. announced positive results from two Phase 2/3 trials evaluating AJOVY (fremanezumab) in patients in Japan. AJOVY is under development in Japan by…
Read More...

Merck, known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental New Drug Application (sNDA)…
Read More...

BetterLife Pharma Inc. announced the acquisition of Swiss based Solmic AG with its strong IP portfolio including unique formulation technology for the production of stable micelles…
Read More...

Applied BioMath, the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, announced a…
Read More...

Avacta Group plc , the developer of Affimer biotherapeutics and reagents, is pleased to announce that it has signed a collaboration and license agreement with AffyXell Therapeutics, the…
Read More...

Catalent and MaSTherCell Global announced that Catalent has agreed to acquire MaSTherCell Global, a company backed by Great Point Partners, SFPI-FPIM, and Orgenesis Inc. for an…
Read More...

Seqirus announced that the U.S. Food and Drug Administration (FDA) has approved AUDENZ (Influenza A (H5N1) Monovalent Vaccine, Adjuvanted) to help protect individuals six months of age…
Read More...